000			05392nam a22004571i 4500
999			_c119186 _d119186 _x1
001			119186
003			ES-MaUEC
005			20230207040637.0
006			a|||| o|||| 00| 0
007			cr nn nnnaamaa
008			200328s2020 si | o |||| 0|eng d
020			_a9789811516955
024	7		_a10.1007/978-981-15-1695-5 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
041	0		_aeng
050		4	_aQR46 _b2020 EB
245	0	0	_aModel Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery _cedited by Busi Siddhardha, Madhu Dyavaiah, Asad Syed
250			_aFirst edition 2020
264		1	_aSingapore _bSpringer International Publishing _c2020
300			_a1 recurso en línea (XVII, 684 páginas) _b91 ilustraciones, 55 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
490	0		_aBiomedical and Life Sciences (Springer-11642)
505	0		_aChapter 1. Microbial infections and virulence factors -- Chapter 2. Microbial Pathogenesis: Virus pathogen-host interactions -- Chapter 3. A physical insight of biofilms -- Chapter 4. A Review on Microbial Pathogenesis and Host Response -- Chapter 5. Role of quorum sensing in microbial infections and biofilm formation -- Chapter 6. Microbial Pathogenesis and Antimicrobial Drug Resistance -- Chapter 7. Pathogenesis and antibiotic resistance of Staphylococcus aureus -- Chapter 8. Pathogenesis, Virulence factors and Antibiotic resistance of Group B Streptococcus -- Chapter 9. Enterococcal infections and Drug resistance mechanisms -- Chapter 10. Pathogenic Escherichia coli: Virulence factors and their Antimicrobial resistance -- Chapter 11. Enterobacter Infections and antimicrobial drug resistance -- Chapter 12. Klebsiella pneumoniae infections and antimicrobial drug resistance -- Chapter 13. Pathogenesis and drug resistance of Pseudomonas aeruginosa -- Chapter 14. Acinetobacter baumannii: Infections and drug resistance -- Chapter 15. Vibrio cholera: Mechanisms of Pathogenicity and Antibiotic resistance -- Chapter 16. Current trends in Mycobacterium tuberculosis pathogenesis and drug resistance -- Chapter 17. PATHOGENESIS OF FUNGAL INFECTIONS AND DRUG- RESISTANCE PHENOMENON -- Chapter 18. Pathogenesis and drug resistance profile of food-borne pathogens -- Chapter 19. Cell lines as in vitro model for studying microbial pathogenesis -- Chapter 20. Animal models to understand host-pathogen interactions -- Chapter 21. Caenorhabditis elegans as pathogenesis model to understand bacterial virulence -- Chapter 22. Zebra fish infection model: From pathogenesis to therapeutics -- Chapter 23. Mycobacterium pathogenesis and drug discovery: Looking through the zebra fish keyhole -- Chapter 24. Murine models to study acute and chronic bacterial infections -- Chapter 25. Non-human primate model use in understanding infectious diseases -- Chapter 26. Understanding Biofilm Dynamics: In Vitro and In Vivo Models -- Chapter 27. Model organisms and antimicrobial drug discovery -- Chapter 28. Yeast: A model organism for antimicrobial drug discovery -- Chapter 29. Caenorhabditis elegans: A tool for antimicrobial drug discovery -- Chapter 30. Zebrafish Model System in Antimicrobial Drug Discovery -- Chapter 31. Murine Models for Development of Anti-Infective Therapeutics -- Chapter 32. Non-human primate models for antimicrobial drug discovery.
520	3		_aThis book provides essential insights into microbial pathogenesis, host-pathogen interactions, and the anti-microbial drug resistance of various human pathogens on the basis of various model organisms. The initial sections of the book introduce readers to the mechanisms of microbial pathogenesis, host-pathogen interactions, anti-microbial drug resistance, and the dynamics of biofilm formation. Due to the emergence of various microbial resistant strains, it is especially important to understand the prognosis for microbial infections, disease progression profiles, and mechanisms of resistance to antibiotic therapy in order to develop novel therapeutic strategies. In turn, the second part of the book presents a comparative analysis of various animal models to help readers understand microbial pathogenesis, host-pathogen interactions, anti-microbial drug discovery, anti-biofilm therapeutics, and treatment regimes. Given its scope, the book represents a valuable asset for microbiologists, biotechnologists, medical professionals, drug development researchers, and pharmacologists alike.
988			_aSpringer_BiomedLife_31032020
650		7	_2embne _9405049 _aMicrobiología médica
650		7	_2embne _9138907 _aBacteriología
700	1		_aSiddhardha, Busi. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aDyavaiah, Madhu. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aSyed, Asad. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted edition: _z9789811516948
776	0	8	_iPrinted edition: _z9789811516962
776	0	8	_iPrinted edition: _z9789811516979
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://dx.doi.org/10.1007/978-981-15-1695-5
942			_2lcc _cLE _n0
998			_b04/2020 _dz _eb _zSI